Return to Vaccination News Home Page __» Right-click to "open in new window"
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
http://archneur.ama-assn.org/cgi/content/abstract/60/7/925
| Vol. 60 No. 7, July 2003 |
|
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurological Review | |||||||||||
Arch Neurol. 2003;60:925-928.
A smallpox vaccination program has been initiated. The
vaccine is a live virus that was used in the last
century. Postvaccinal encephalitis is a complication of
this vaccine. The clinical presentation, course,
neuroimaging findings, and spinal fluid abnormalities are
similar to a disorder that physicians are familiar with,
acute disseminated encephalomyelitis. This complication
can be prevented with the administration of antivaccinia gamma
globulin at the time of vaccination. Antivaccinia gamma
globulin is not efficacious once this complication
occurs. Intravenous methylprednisolone is the recommended
therapy, although intravenous immunoglobulin and
plasmapheresis should be investigated in the treatment of
postvaccinal encephalitis. RELATED ARTICLES IN ARCHIVES OF NEUROLOGY
This Month in Archives of Neurology |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 American Medical Association. All Rights Reserved.
Return to Vaccination News Home Page __» Right-click to "open in new window"
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.